Characterization of LDL particle size among carriers of a defective or a null mutation in the lipoprotein lipase gene: The Québec LIPD study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 7, 2002, Pages 1181-1186

  Ruel, Isabelle L ^a,b   Gaudet, Daniel ^c   Perron, Patrice ^c   Bergeron, Jean ^b   Julien, Pierre ^b   Lamarche, Benoît ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Defects; Gene; LDL particle size; Lipoprotein lipase; Lipoproteins

Indexed keywords

CHOLESTEROL; GENE PRODUCT; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HETEROZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PARTICLE SIZE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036068378     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000020677.33243.1C     Document Type: Article

References (31)

1. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
2. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
3. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
4. Small, dense LDL particles and the risk of ischemic heart disease: Prospective results from the Québec Cardiovascular Study
5. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men
6. Low-density lipoprotein subclass patterns and risk of myocardial infarction
7. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk
8. The dense LDL phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
9. Atherosclerosis prevention for the next decade: Risk assessment beyond LDL cholesterol
10. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides
11. Primary lipoprotein-lipase-activity deficiency: Clinical investigation of a French Canadian population
12. A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians
13. Molecular pathobiology of the human lipoprotein lipase gene
14. Functional variants in the lipoprotein lipase gene and risk cardiovascular disease
15. A common variant in the gene for lipoprotein lipase (Asp9-> Asn). Functional implications and prevalence in normal and hyperlipidemic subjects
16. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities
17. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency
18. A single threshold value of waist girth identifies normal-weight and over-weight subjects with excess visceral adipose tissue
19. Classification and diagnosis of diabetes and other categories of glucose intolerance
20. Mismatch PCR: A rapid method to screen for the Pro207->Leu mutation in the lipoprotein lipase (LPL) gene
21. A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro
22. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol
23. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
24. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
25. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
26. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
27. Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study
28. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency
29. Plasma cholesteryl ester transfer protein
30. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
31. Lipoprotein lipase binding to plasma lipoproteins